These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 12775126

  • 1. Do leukotriene receptor antagonists have a place in pharmacotherapy of allergic rhinitis?
    Nathan RA.
    Ann Allergy Asthma Immunol; 2003 May; 90(5):466-8. PubMed ID: 12775126
    [No Abstract] [Full Text] [Related]

  • 2. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
    Ratner PH, Howland WC, Arastu R, Philpot EE, Klein KC, Baidoo CA, Faris MA, Rickard KA.
    Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.
    Martin BG, Andrews CP, van Bavel JH, Hampel FC, Klein KC, Prillaman BA, Faris MA, Philpot EE.
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):851-7. PubMed ID: 16802774
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
    Wilson AM, Sims EJ, Orr LC, Coutie WJ, White PS, Gardiner Q, Lipworth BJ.
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
    Hung CH, Hua YM, Hsu WT, Lai YS, Yang KD, Jong YJ, Chu YT.
    Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS, Philip G, Lu S, Malice MP, Reiss TF, Montelukast Fall Rhinitis Investigator Group.
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety of fixed-dose loratadine/montelukast in subjects with allergic rhinitis.
    Prenner BM, Lu S, Danzig MR.
    Allergy Asthma Proc; 2010 Jun; 31(6):493-8. PubMed ID: 21708061
    [Abstract] [Full Text] [Related]

  • 18. Combined mediator antagonism for allergic rhinitis.
    Jackson CM, Lipworth BJ.
    Allergy; 2004 Mar; 59(3):276-9. PubMed ID: 14982508
    [No Abstract] [Full Text] [Related]

  • 19. Seasonal allergic rhinitis.
    Sheikh A, Panesar S, Dhami S.
    Clin Evid; 2003 Jun; (9):585-97. PubMed ID: 12967381
    [No Abstract] [Full Text] [Related]

  • 20. Fluticasone furoate nasal spray is the only intranasal corticosteroid to reduce the ocular symptoms of seasonal allergic rhinitis consistently.
    Keith P, Lee LA.
    J Allergy Clin Immunol; 2011 Jan; 127(1):288-9; author reply 289. PubMed ID: 21047674
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.